How to judge the evidence on a new pet therapy

5 min read · Reviewed by Dr. Elena Ruiz, DVM

The short answer

When you're weighing a new therapy for your dog, judge the evidence by three questions: what species was it studied in, how big and controlled was the study, and who's making the claim. Strong evidence is replicated, controlled, and ideally in the target species; early evidence is small, preclinical, or in other animals. Neither is worthless — but only one justifies a promise, and honest providers rate their own evidence plainly, including the weak parts.

Key takeaways

Ask: which species, how big and controlled, and who benefits from the claim.
Rodent and cell-culture results are a starting point, not proof for dogs.
'Clinically proven' with no study behind it is a marketing phrase, not evidence.
Trust providers who rate their own evidence honestly — including the Limited parts.

Three questions that cut through most claims

You don't need a science degree to weigh a claim well. You need three questions:

In what species was it studied? A result in dogs is worth far more to you than a result in rats or a test tube — and most peptide research is in the latter.
How big and controlled was the study? A handful of animals with no comparison group is a hint; dozens of subjects with a control group is evidence.
Who's making the claim, and what do they gain? A rating from someone selling the product deserves more scrutiny than an independent one.

What 'strong' and 'limited' actually mean

It helps to think in tiers. Strong evidence is replicated, controlled and adequately sized. Moderate is a single good study, or consistent results from small ones. Limited is small, observational, or in a different species — which is honestly where most canine peptide data sits today.

Red flags of hype

The words cure, reverse, miracle, or guarantee. Real medicine almost never talks this way.
Before-and-after promises, or a stated success rate with no study attached.
'Clinically proven' or 'vet approved' with no vet named and no study you can find.
No mention of who it's not for. Everything real has contraindications.
Countdown timers and 'only 3 left' urgency on a health decision.

Common questions

If the evidence in dogs is limited, why consider peptides at all?

Because 'limited' means early, not disproven, and many accepted treatments began here. The reasonable path is a supervised trial for suitable dogs — with a vet weighing the early evidence against your dog, and honest check-ins on whether it's helping.

How can I check a provider's claims myself?

Ask for the certificate of analysis on a batch, ask which studies support a specific claim and in what species, and see whether they'll tell you who the therapy isn't for. Legitimate providers answer all three without flinching.

On the evidence

This library is educational, not veterinary advice, and it isn't a substitute for examining your own dog. Where we describe what research shows, we name the kind of study it comes from — most peptide evidence is preclinical or from other species, with canine-specific data still small. Formal citations are maintained by our clinical team and available on request at hello@petpides.com.